Computer-aided diagnosis and prediction in brain disorders

  title={Computer-aided diagnosis and prediction in brain disorders},
  author={Vikram Venkatraghavan and Sebastian R. van der Voort and Daniel Bos and Marion Smits and Frederik Barkhof and Wiro J. Niessen and Stefan Klein and Esther E. Bron},
Computer-aided methods have shown added value for diagnosing and predicting brain disorders and can thus support decision making in clinical care and treatment planning. This chapter will provide insight into the type of methods, their working, their input data - such as cognitive tests, imaging and genetic data - and the types of output they provide. We will focus on specific use cases for diagnosis, i.e. estimating the current ‘condition’ of the patient, such as early detection and diagnosis… 

Figures from this paper



Diagnostic neuroimaging across diseases

Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects.

It is shown that the disease index values derived from heterogeneous patient data can be used for identifying groups of patients for whom the prediction accuracy reaches the previously set target level.

Multiparametric computer-aided differential diagnosis of Alzheimer’s disease and frontotemporal dementia using structural and advanced MRI

Combining ASL and DTI with structural MRI resulted in higher classification performance for differential diagnosis of AD and FTD than using structural MRI by itself, suggesting complementary information.

Three-Class Differential Diagnosis among Alzheimer Disease, Frontotemporal Dementia, and Controls

The results demonstrate that local atrophy features in lateral ventricles offer the potential to be a biomarker in discriminating among AD, FTD, and NC in a three-class setting for individual patient classification.

Ten years of image analysis and machine learning competitions in dementia

Imaging plus X: multimodal models of neurodegenerative disease

It is argued that the time is approaching for data-driven disease modelling to take centre stage in the study and management of neurodegenerative disease, and this will make disease progression modelling invaluable for recruitment and end-points in future clinical trials, potentially ameliorating the high failure rate in trials of, e.g., Alzheimer's disease therapies.

Multivariate data analysis and machine learning in Alzheimer's disease with a focus on structural magnetic resonance imaging.

Recent studies are reviewed that have used machine learning and multivariate analysis in the field of AD research, focusing on studies that used structural magnetic resonance imaging (MRI) and studies that included positron emission tomography and cerebrospinal fluid biomarkers in addition to MRI.

Five-class differential diagnostics of neurodegenerative diseases using random undersampling boosting